Heidi Hagan


Ms. Hagen is currently the Interim Chief Executive Officer of Ziopharm. She has served on the Board of Ziopharm since June 2019 and the Board of Vericel since 2013.

She is a 30-year veteran of the biotechnology industry, the last 20 in cell and gene therapy. Ms. Hagen is co-founder of Vineti, a cloud-based software platform company that address...


Roles at Lykan Bioscience

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.